Avaleht › Lupuse nefriit › California
Lupuse nefriit kliinilised uuringud osariigis California
15 uuringut haiguse Lupuse nefriit jaoks otsivad osalejaid osariigis California.
Linnad osariigis California
Ametlik uuringutekst (inglise keeles)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Ronald Reagan UCLA Medical Center, Los Angeles
VärbamineFaas 2
Vanused 18–100 · Kõik sood · Uuendatud 1. okt 2026 · NCT05268289VIBRANT: VIB4920 for Active Lupus Nephritis
- University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology, La Jolla
- UCLA Medical Center: Division of Rheumatology, Los Angeles
- of California, Irvine School of Medicine Division of Rheumatology, Orange
- ja veel 1
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT05201469Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- University of California San Francisco - Zuckerberg San Francisco General, San Francisco
VärbamineFaas 1
Vanused 18–60 · Kõik sood · Uuendatud 14. sept 2026 · NCT06975787The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- University of California, San Francisco, San Francisco
VärbamineFaas 2
Vanused 8–20 · Kõik sood · Uuendatud 14. sept 2026 · NCT05538208A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Wallace Rheumatic Studies Center, Beverly Hills
- Kaiser Permanente Fontana, Fontana
- Providence Medical Foundation, Fullerton
- ja veel 2
VärbamineFaas 2
Vanused 12–70 · Kõik sood · Uuendatud 14. sept 2026 · NCT07570862A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, San Francisco
- Research Site, Stanford
VärbamineFaas 1/2
Vanused 18–70 · Kõik sood · Uuendatud 10. sept 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
VärbamineFaas 1
Vanused 18–74 · Kõik sood · Uuendatud 10. sept 2026 · NCT07085104A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Loma Linda University health, Loma Linda
- UCSF Benioff Childrens Hospital, San Francisco
VärbamineFaas 2
Vanused 5–17 · Kõik sood · Uuendatud 3. sept 2026 · NCT05039619A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- UC San Diego Health, La Jolla
- Stanford University Medical Center, Redwood City
VärbamineFaas 1
Vanused 18–70 · Kõik sood · Uuendatud 28. aug 2026 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of California Irvine, Orange
- UC Davis Health, Sacramento
VärbamineFaas 1/2
Vanused 18–65 · Kõik sood · Uuendatud 26. aug 2026 · NCT06121297PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Purushotham & Akther Kotha MD, Inc., La Mesa
- Valerius Medical Group & Research Center of Greater Long Beach, Inc., Los Alamitos
VärbamineFaas 4
Vanused 18–75 · Kõik sood · Uuendatud 3. aug 2026 · NCT07611214A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, Tustin
VärbamineFaas 1/2
Vanused 18–75 · Kõik sood · Uuendatud 4. juuni 2026 · NCT06557265A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- ja veel 2
VärbamineFaas 1
Vanused 12–70 · Kõik sood · Uuendatud 22. mai 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Wallace Rheumatic Studies Center, Beverly Hills
- UCLA, Los Angeles
VärbamineVaatlusuuring
Vanused 18–110 · Kõik sood · Uuendatud 15. apr 2026 · NCT05934149Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
- Lucile Packard Children's Hospital, Palo Alto
VärbamineFaas 1/2
Vanused 1–30 · Kõik sood · Uuendatud 17. juuli 2023 · NCT05508009Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.